Spero Therapeutics, Inc. (SPRO)
NASDAQ: SPRO · Real-Time Price · USD
1.190
-0.010 (-0.83%)
Nov 21, 2024, 4:00 PM EST - Market closed

Spero Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2015
Period Ending
Nov '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2015
Market Capitalization
657890518527184
Upgrade
Market Cap Growth
13.54%-13.02%-82.69%-1.83%186.63%73.81%
Upgrade
Enterprise Value
-6-104640140895
Upgrade
Last Close Price
1.201.471.7316.0119.399.62
Upgrade
PE Ratio
19.773.42----
Upgrade
PS Ratio
0.600.751.6728.3556.5010.13
Upgrade
PB Ratio
0.990.731.185.863.992.47
Upgrade
P/TBV Ratio
1.110.731.185.863.992.47
Upgrade
EV/Sales Ratio
0.13-0.8621.9843.725.24
Upgrade
Debt / Equity Ratio
0.070.050.090.630.060.07
Upgrade
Debt / EBITDA Ratio
9.280.19----
Upgrade
Asset Turnover
0.880.680.360.110.070.15
Upgrade
Quick Ratio
2.643.425.097.989.283.40
Upgrade
Current Ratio
2.683.535.258.469.703.58
Upgrade
Return on Equity (ROE)
5.89%24.95%-56.53%-81.47%-75.77%-63.99%
Upgrade
Return on Assets (ROA)
-0.57%10.90%-12.91%-33.88%-38.10%-33.61%
Upgrade
Return on Capital (ROIC)
-1.06%17.17%-16.86%-38.73%-44.95%-40.32%
Upgrade
Earnings Yield
5.37%29.27%-51.82%-17.34%-14.85%-33.13%
Upgrade
FCF Yield
-26.80%-42.35%-8.63%-12.43%-16.32%-27.37%
Upgrade
Buyback Yield / Dilution
-4.41%-40.98%-21.65%-38.01%-23.27%-13.49%
Upgrade
Total Shareholder Return
-4.41%-40.98%-21.65%-38.01%-23.27%-13.49%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.